Matches in Nanopublications for { ?s ?p "[In conclusion, the results of the present study demonstrated that PI3K/AKT and Rab25 significantly contributed to cisplatin resistance in human epithelial ovarian cancer; in addition, silencing Rab25 or inhibiting the PI3K/AKT pathway markedly increased the sensitivity of these cells to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP1238231.RABfzqyzLvDJeX6bPw75BVm8bPLO5OSa9i9Lj2GMrStt4130_assertion description "[In conclusion, the results of the present study demonstrated that PI3K/AKT and Rab25 significantly contributed to cisplatin resistance in human epithelial ovarian cancer; in addition, silencing Rab25 or inhibiting the PI3K/AKT pathway markedly increased the sensitivity of these cells to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238231.RABfzqyzLvDJeX6bPw75BVm8bPLO5OSa9i9Lj2GMrStt4130_provenance.
- NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_assertion description "[In conclusion, the results of the present study demonstrated that PI3K/AKT and Rab25 significantly contributed to cisplatin resistance in human epithelial ovarian cancer; in addition, silencing Rab25 or inhibiting the PI3K/AKT pathway markedly increased the sensitivity of these cells to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_provenance.
- NP1238228.RAnrsv7uEMCpRX4dpZhyV4DkBFBDlTAGFhr-Ql17sIIAo130_assertion description "[In conclusion, the results of the present study demonstrated that PI3K/AKT and Rab25 significantly contributed to cisplatin resistance in human epithelial ovarian cancer; in addition, silencing Rab25 or inhibiting the PI3K/AKT pathway markedly increased the sensitivity of these cells to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238228.RAnrsv7uEMCpRX4dpZhyV4DkBFBDlTAGFhr-Ql17sIIAo130_provenance.
- NP1238232.RAp68Af4WKiLXSmKxBSAYBEln5_O3V3PCKdsd8NDwY-EM130_assertion description "[In conclusion, the results of the present study demonstrated that PI3K/AKT and Rab25 significantly contributed to cisplatin resistance in human epithelial ovarian cancer; in addition, silencing Rab25 or inhibiting the PI3K/AKT pathway markedly increased the sensitivity of these cells to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238232.RAp68Af4WKiLXSmKxBSAYBEln5_O3V3PCKdsd8NDwY-EM130_provenance.